GRAIL Completes Enrollment of More Than 35,000 Participants in the PATHFINDER 2 Study; Results From the First 25,000 Participants Expected in the Second Half of 2025 GRAIL Completes Final Study Visits ...
The goals of the program are to: a) enhance the scientific return from the GRAIL mission by broadening participation in the mission, and b) augment the existing GRAIL science team to include new ...
GRAIL Inc., spun off from Illumina Inc. in June 2024, faces financial challenges but holds significant growth potential with its Galleri cancer-screening test. Despite a strong balance sheet, GRAIL's ...
NASA’s twin GRAIL spacecraft were delivered by its builder Lockheed Martin (NYSE: LMT) to Kennedy Space Center, Fla., on May 20. The two vehicles will undergo four months of final testing and ...
Results From the First 25,000 Participants Expected in the Second Half of 2025 GRAIL Completes Final Study Visits for the NHS-Galleri Trial; Final Results Expected in 2026 PATHFINDER 2 is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results